Influence of height on blood pressure and hypertension among Bangladeshi adults

A Study on Prevalence and Factors Affecting Hypertension in an Iranian Population: Results from the Fasa Cohort Study

Background

In recent years, hypertension has been one of the most important noncommunicable diseases worldwide. In this context, identifying the predictors of this disease can help health policymakers to reduce its burden. This study aimed to identify some of the most important influential factors of hypertension and present a model to predict this disease in the data from a large sample cohort study.

Methods

The data set included 10,138 people from the baseline phase of the Fasa cohort study during 2014 and 2016. The main outcome under study was having hypertension in the baseline phase of the study according to self-reports or medical examinations. To identify the related factors of hypertension, logistic regression, classification tree, and random forest models were utilized. Statistical analyses were performed in R.

Results

Among the 10,138 people examined, 2819 (27.8%) had hypertension. In the initial screening, 39 variables were regarded as potential indicators of hypertension. After preliminary analysis, 11 variables were recognized as important predictors based on the importance index: history of cardiovascular disease, cardiac disease, waist circumference to height ratio, body mass index, sex, hypertension in a first-degree relative, weight, fatty liver, cardiac disease in a first-degree relative, diabetes in a first-degree relative, and energy intake. The area under the receiving operating characteristic (ROC) curve for predicting hypertension using logistic regression, classification tree, and random forest models was about 72.8%, 73%, and 87.6%, respectively. Also, the accuracy of these models was 65.2%, 67.4% and 77.8%, respectively.

Conclusion

In general, our findings showed that machine learning-based approaches, such as random forest models, outperformed classical methods, such as logistic regression in predicting hypertension. Regarding the rather high prevalence of hypertension in the population under study, there is an urgent need to pay more attention to its indicators for early diagnosis of the patients and reducing the burden of this silent disease in our country.

Epigallocatechin gallate enhances sympathetic heart rate variability and decreases blood pressure in obese subjects: a randomized control trial

This study aimed to investigate effects of epigallocatechin gallate (EGCG) on blood pressure (BP) and autonomic nervous system, indicated by 5-min heart rate variability (HRV) measurement in obese subjects, and determine correlations of BP with metabolic factors. In a double-blind, randomized controlled trial, obese subjects (n = 30) were randomly allocated to receive 150 mg EGCG (n = 15) or placebo (n = 15) twice a day without dietary restrictions. After 8-week EGCG treatment, systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) significantly decreased, while the low-frequency (LF) to high-frequency power (HF) ratio (LF/HF ratio) significantly increased (P < 0.05 all), indicating a shift toward sympathetic dominance, either directly or indirectly after BP lowering. SBP had positive correlations with obesity parameters, leptin, insulin, and insulin resistance but had a negative correlation with insulin sensitivity. DBP was positively correlated with age and HF in normalized unit, but negatively correlated with height and LF in ms2. High-density lipoprotein cholesterol (HDL-C) was negatively correlated with SBP, DBP, and MAP reflecting its protective effect against elevated BP. In conclusion, the 8-week EGCG treatment decreased BP and increased the LF/HF ratio, reflecting increased sympathetic activity, either a direct EGCG effect or an indirect compensatory response following BP reduction.

Body height among adult male and female Swiss Health Survey participants in 2017: Trends by birth years and associations with self-reported health status and life satisfaction

•

Increase in average body height had slowed down from around the 1970s birth cohorts.

•

Women and men with tertiary education levels were taller than participants holding other education levels.

•

Taller participants were less overweighted and were more satisfied with their lives than shorter participants.

•

Taller participants had better overall health than shorter participants.

•

Taller men were more likely to have lower back pain than shorter men.

The increase in adult height for 150 years is linked to overall improvements in nutrition, hygiene, and living standards. Height is positively associated with general health and success on various levels (e.g. quality of life, earnings or happiness). The aim of this study was to investigate whether different subgroups show different trends across birth cohorts. We wanted to know whether taller individuals considered themselves as healthier and their quality of life as better than shorter individuals.

We included 19,435 participants from the Swiss population-based Health Survey 2017. GAM were used to assess nonlinear associations between height and birth year. Multinomial logistic regression was used to predict probabilities of self-rated health in relation to height.

The increase in average height slows down from the 1970s birth cohorts. Participants with parents from Central/Northern/Western Europe (men 177.9 cm, women: 165.1 cm) or Eastern Europe (men 178.7 cm, women: 165.7 cm) were taller than participants with parents from South America (men 174.3 cm, women: 161. cm) and Asia (men 173.2 cm, women: 160.1 cm). Participants with tertiary education were taller than participants from education levels (mean difference men: 4.5 cm, women: 5.0 cm). Height was positively associated with self-declared aspects of health and life satisfaction.

These results support the conclusion that body height as a co-factor of health aspects should be considered in public health research. Although adult body height can no longer be influenced, nutritional status and thus also healthy growth can be influenced in childhood by public health programs, by eliminating social inequalities, and by strengthen healthy living conditions.

Body height in adult women and men in a cross-sectional population-based survey in Geneva: temporal trends, association with general health status and height loss after age 50

OBJECTIVE

On the one hand, trends in average height in adulthood mirror changes in living standard and health status of a population and its subgroups; on the other hand, height in general, as well as the loss of height in older age in particular, are associated in different ways with outcomes for health. For these aspects, there is hardly any information for Switzerland based on representative and measured body height data.

DESIGN

Repeated cross-sectional survey study.

SETTING

Fully anonymised data from the representative population-based Geneva Bus Santé Study between 2005 and 2017 were analysed.

METHODS

Data from N=8686 study participants were used in the trend analysis. Height was measured and sociodemographic information and self-rated health was collected via questionnaires. Follow-up (mean: 7.1 years) measurements from N=2112 participants were available to assess height loss after age 50.

RESULTS

Women were, on average, 166.2 cm (SD 6.5) tall and men 179.2 cm (SD 6.5). Among men and women, higher socioeconomic status was associated with taller average height. The flattening of the increase in height from the 1970s birth years appears to begin earlier in the subgroup with the highest education level. The tallest average height was measured for men and women from Central and Northern Europe, the shortest for South America and Asia. The likelihood that participants rated their health as 'very good' increased with greater body height. The follow-up data show that men lost -0.11 cm per follow-up year (95% CI -0.12 to -0.10), women -0.17 cm (95% CI -0.18 to 0.15).

CONCLUSIONS

The association of height and health status is currently understudied. Monitoring changes in average body height may indicate disparities in different subgroups of populations. Based on our study and a growing literature, we think that the multifaceted role of body height should be better considered in clinical practice.